CRP and myocardial infarction: In order to obtain a clear answer, we performed a systematic review and a meta-analysis of randomized controlled trials (RCTs) which evaluated the effects of statins in lowering CRP and hs-CRP levels in different types of CVDs, such as ACS, myocardial infarction (MI), coronary artery disease (CAD), unstable angina, heart failure, stable atherosclerotic plaque, and carotid artery stenting.